U.S. stocks are on the move | The weight loss drug Zepbound is expected to be approved in japan next year, eli lilly (LLY.US) rose more than 1%.

Zhitong Finance · Oct 11 22:53

On Friday, Eli Lilly and Co (LLY.US) stock price fluctuated upwards, as of the time of writing, it rose by 1.18%, reaching $921.435.

According to the Wisdom Financial APP, on Friday, Eli Lilly and Co (LLY.US) stock price fluctuated upwards, rising by 1.18% as of the time of writing, reaching $921.435. On the news front, the CEO of Eli Lilly and Co stated on Friday that the weight loss drug Zepbound is expected to be approved in Japan next year.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

美股异动 | 减肥药Zepbound有望明年在日本获批 礼来(LLY.US)涨逾1%

U.S. stocks are on the move | The weight loss drug Zepbound is expected to be approved in japan next year, eli lilly (LLY.US) rose more than 1%.

Risk Disclaimer

Statement

美股异动 | 减肥药Zepbound有望明年在日本获批礼来(LLY.US)涨逾1%